1,408
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pembrolizumab for the treatment of colorectal cancer

, , , &
Pages 219-226 | Received 01 Sep 2019, Accepted 15 Jan 2020, Published online: 03 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Louis Plüss, Frederik Peissert, Abdullah Elsayed, Giulia Rotta, Jonas Römer, Sheila Dakhel Plaza, Alessandra Villa, Emanuele Puca, Roberto De Luca, Annette Oxenius & Dario Neri. (2023) Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. mAbs 15:1.
Read now
Paolo Tarantino, Romualdo Barroso-Sousa, Ana C. Garrido-Castro, Sandra S. McAllister, Jennifer L. Guerriero, Elizabeth Mittendorf, Giuseppe Curigliano & Sara M. Tolaney. (2022) Understanding resistance to immune checkpoint inhibitors in advanced breast cancer. Expert Review of Anticancer Therapy 22:2, pages 141-153.
Read now
Xianzhe Yu, Lingling Zhu, Jiewei Liu, Ming Xie, Jiang Chen & Jianguo Li. (2020) Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis. OncoTargets and Therapy 13, pages 11645-11658.
Read now

Articles from other publishers (12)

Chao Li, Ulrich Wirth, Josefine Schardey, Viktor V. Ehrlich-Treuenstätt, Alexandr V. Bazhin, Jens Werner & Florian Kühn. (2023) An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer. Frontiers in Immunology 14.
Crossref
Mayur M. Amonkar, Lauren A. Abderhalden, Andrew M. Frederickson, Audrone Aksomaityte, Brian M. Lang, Pierre Leconte & Ina Zhang. (2023) Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis. International Journal of Colorectal Disease 38:1.
Crossref
Pramodkumar P. Gupta, Mala M. Parab, Santosh S. Chhajed & Virupaksha A. Bastikar. 2023. Protein-based Therapeutics. Protein-based Therapeutics 275 296 .
Frederik Peissert, Louis Plüss, Anna Maria Giudice, Tiziano Ongaro, Alessandra Villa, Abdullah Elsayed, Lisa Nadal, Sheila Dakhel Plaza, Luigi Scietti, Emanuele Puca, Roberto De Luca, Federico Forneris & Dario Neri. (2022) Selection of a PD ‐1 blocking antibody from a novel fully human phage display library . Protein Science 31:12.
Crossref
Lili Huang, Huaxin Zhao, Mengying Shan, Hong Chen, Bin Xu, Yang He, Yu Zhao, Zhuqing Liu, Jianhua Chen & Qing Xu. (2022) Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD ‐1 monotherapy in colorectal cancer . Cancer Medicine 11:23, pages 4575-4587.
Crossref
Jiawei Chen, Haodong Zhu, Yuhang Yin, Siyuan Jia & Xiangjian Luo. (2022) Colorectal cancer: Metabolic interactions reshape the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188797.
Crossref
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll & Guangfu Li. (2022) Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 14:8, pages 1630.
Crossref
Sara Cherri, Ester Oneda, Silvia Noventa, Laura Melocchi & Alberto Zaniboni. (2022) Microsatellite instability and chemosensitivity in solid tumours. Therapeutic Advances in Medical Oncology 14, pages 175883592210993.
Crossref
Monika Berbecka, Alicja Forma, Jacek Baj, Marzena Furtak-Niczyporuk, Ryszard Maciejewski & Robert Sitarz. (2021) A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. Journal of Clinical Medicine 10:19, pages 4443.
Crossref
N.A. Bhaskaran & L. Kumar. (2021) Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. Journal of Controlled Release 336, pages 16-39.
Crossref
Junge Bai, Hongsheng Chen & Xuefeng Bai. (2021) Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment. Journal of Clinical Laboratory Analysis 35:6.
Crossref
Huilin Ma, Hanwen Wang, Richard J Sové, Jun Wang, Craig Giragossian & Aleksander S Popel. (2020) Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model. Journal for ImmunoTherapy of Cancer 8:2, pages e001141.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.